Literature DB >> 28466657

A Review on Potential Involvement of TRPV1 Channels in Ischemia-Reperfusion Injury.

Puneet Kaur Randhawa1, Amteshwar Singh Jaggi1.   

Abstract

Besides functioning as thermosensors, transient receptor potential vanilloid 1 (TRPV1) channels play a pivotal role in ischemia-reperfusion injury. Transient receptor potential vanilloid 1 channel activation attenuates ischemia-reperfusion-induced injury in various organs including the heart, lungs, kidneys, and the brain. Transient receptor potential vanilloid 1 channels are expressed on the sensory neurons innervating the myocardium, ventricles of the heart, epicardial surface of the heart, endothelial cells, and the vascular smooth muscle cells. During ischemic conditions, activation of TRPV1 channels on the perivascular nerves stimulates the release of calcitonin gene-related peptide and substance P to produce cardioprotection. Furthermore, TRPV1 channel activation reduces the generation of free radicals and inflammatory cytokines, inhibits neutrophil infiltration, and enhances the production of anti-inflammatory cytokines to reduce ischemia-reperfusion-induced tissue injury. The present review describes the potential involvement of TRPV1 channels and the signaling cascade in attenuating ischemia-reperfusion injury in various organs.

Entities:  

Keywords:  CGRP; TRPV1 channels; heart; ischemia; substance P

Mesh:

Substances:

Year:  2017        PMID: 28466657     DOI: 10.1177/1074248417707050

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  7 in total

1.  12(S)-HETE mediates diabetes-induced endothelial dysfunction by activating intracellular endothelial cell TRPV1.

Authors:  Mandy Otto; Clarissa Bucher; Wantao Liu; Melanie Müller; Tobias Schmidt; Marina Kardell; Marvin Noel Driessen; Jan Rossaint; Eric R Gross; Nana-Maria Wagner
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

2.  Transient Receptor Potential Vanilloid 1 Expression Mediates Capsaicin-Induced Cell Death.

Authors:  Ricardo Ramírez-Barrantes; Claudio Córdova; Sebastian Gatica; Belén Rodriguez; Carlo Lozano; Ivanny Marchant; Cesar Echeverria; Felipe Simon; Pablo Olivero
Journal:  Front Physiol       Date:  2018-06-05       Impact factor: 4.566

Review 3.  Endothelial TRPV1 as an Emerging Molecular Target to Promote Therapeutic Angiogenesis.

Authors:  Sharon Negri; Pawan Faris; Vittorio Rosti; Maria Rosa Antognazza; Francesco Lodola; Francesco Moccia
Journal:  Cells       Date:  2020-05-27       Impact factor: 6.600

4.  TRPV1 translocated to astrocytic membrane to promote migration and inflammatory infiltration thus promotes epilepsy after hypoxic ischemia in immature brain.

Authors:  Xin Wang; Xing-Liang Yang; Wei-Lin Kong; Meng-Liu Zeng; Lin Shao; Guang-Tong Jiang; Jing-Jing Cheng; Shuo Kong; Xiao-Hua He; Wan-Hong Liu; Tao-Xiang Chen; Bi-Wen Peng
Journal:  J Neuroinflammation       Date:  2019-11-13       Impact factor: 8.322

5.  A Potential Involvement of Anandamide in the Modulation of HO/NOS Systems: Women, Menopause, and "Medical Cannabinoids".

Authors:  Renáta Szabó; Denise Börzsei; Zsuzsanna Szabó; Alexandra Hoffmann; István Zupkó; Dániel Priksz; Krisztina Kupai; Csaba Varga; Anikó Pósa
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 6.  Role of Bile Acids and Bile Salts in Acute Pancreatitis: From the Experimental to Clinical Studies.

Authors:  Quang Trung Tran; Van Huy Tran; Matthias Sendler; Julia Doller; Mats Wiese; Robert Bolsmann; Anika Wilden; Juliane Glaubitz; Jana Marielle Modenbach; Franziska Gisela Thiel; Laura L de Freitas Chama; Frank Ulrich Weiss; Markus M Lerch; Ali A Aghdassi
Journal:  Pancreas       Date:  2021-01-01       Impact factor: 3.243

Review 7.  Transient Receptor Potential Vanilloid in the Brain Gliovascular Unit: Prospective Targets in Therapy.

Authors:  Huilong Luo; Xavier Declèves; Salvatore Cisternino
Journal:  Pharmaceutics       Date:  2021-03-04       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.